-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-adults-children-adolescents-screening-2003
April 01, 2003 - No longer-term studies of the effects of medications in children are available.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
June 15, 2012 - differences in blood pressure and fasting glucose levels at 12 months; however, these differences were no longer
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2002
December 01, 2002 - detected cancers, and the delay between treatment and benefit (5 years in this study) is likely to be even longer
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-children-and-adolescents-primary-care-interventions-2013
August 15, 2013 - intervention components and determine their feasibility in real-world primary care practice; incorporate longer-term
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/visual-impairment-in-children-ages-1-5-screening-2011
January 15, 2011 - good-quality trials found no differences in visual acuity improvement in the affected eye between shorter and longer
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
May 15, 2004 - on small numbers of cancers, and studies varied in length of followup, although most did not extend longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
May 23, 2019 - Some people
will have a longer and some a shorter asymptomatic period.
Table 1. … harm of screening is subjecting pa-
tients to a potentially harmful or unnecessary treatment for
a longer … A longer preclinical period provides a better op-
portunity for early treatment to reduce complications
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
July 01, 2013 - Assessment of Risk) for new
HIV infection at least annually and individuals at increased
risk at somewhat longer … Longer-term use of
ART regimens may increase the risk for cardiovascular and
bone disease, as well as
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
April 30, 2024 - on 2 studies, false-positive results were more likely to occur with annual screening compared with longer … mammography as long as their overall health is good and they have a life expectancy of 10 years or longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KT7vaWK_JSDNNvEmUAjN8d
May 01, 2018 - prognosis, the frequency of
overdiagnosis will be greater in a population with a shorter rather than longer … interval, such that
screening at older ages was associated with a higher estimated overdiagnosis and a longer … detected
during patient’s lifetime
Frequency of overdiagnosis depends on sojourn time
(increases w ith longer
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary--html/cardiovascular-disease-screening-using-nontraditional-risk-assessment
July 10, 2018 - strata of less than 10%, 10% to 19%, and 20% or greater. 39 The NRIs based on these 3 strata are no longer … Additionally, many studies used 3 risk strata, which is no longer as relevant to current clinical practice … Ancillary: The article met inclusion criteria, but more complete data such as a larger sample or longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF_Y9vcT3eNPdHjTxPZsUZ
April 17, 2023 - or who were above a prespeci-
fied depression symptom score (“prevalence”), the proportion who
no longer … of
treatment response (OR, 1.52 [95% CI, 1.40-1.66]).1,58 Limited evi-
dence was available on the longer-term
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
May 24, 2022 - not detected
Moderate for
similar benefit
Aflibercept was FDA approved for AMD in 2011 and
with a longer … South America)
Newer vs older VEGF inhibitors:
Aflibercept was FDA approved for AMD in 2011
and with a longer
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
January 23, 2024 - Treatment studies are needed of screen-detected populations that follow children over short and longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/GytpQk-RYN3yBfdzkqUpff
January 23, 2024 - children
Treatment studies are needed of screen-detected populations that follow children over short and longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/T-DyWdyD67ktDMJGDp3jpm
June 01, 2003 - caregiver interventions enabled the caregivers to
maintain affected persons at home for 11 to 19
months longer
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2002
September 17, 2002 - , a minimum of 2 years may be needed to reliably measure a change in bone mineral density; however, longer
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
May 01, 2018 - prognosis, the frequency of
overdiagnosis will be greater in a population with a shorter rather than longer … interval, such that
screening at older ages was associated with a higher estimated overdiagnosis and a longer … detected
during patient’s lifetime
Frequency of overdiagnosis depends on sojourn time
(increases w ith longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
January 01, 2017 - Most trials
lasted for 12 weeks or less, but 5 trials treated participants for 24
weeks or longer,70,96,97,99,107 … 12 weeks or less in duration; 5 followed
up participants for 24 weeks,70,99 48 to 52 weeks,96,107 or
longer … trials followed up partici-
pants for 12 weeks or less; 4 trials measured outcomes over 24
weeks or longer … either in the
CPAP group99 or in the sham CPAP group at 12 weeks.63 Two RCTs
assessed mortality over a longer
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DTRggkjEPQ5-ALArTjrhKT
July 11, 2017 - There is very limited evidence on longer-term intermediate and health outcomes or on
harmful effects … Very few trials reported longer-term effects (ie, greater
than 12 months of follow-up) on intermediate … The evidence for the effects of interventions on longer-term
health outcomes, including all-cause and … There is very limited evidence on longer-term interme-
diate and health outcomes or on harmful effects